IFP Advisors’s Histogen Inc. Common Stock HSTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-41
Closed -$11K 3672
2018
Q4
$11K Buy
+41
New +$31.9K ﹤0.01% 2480
2018
Q3
Sell
-28
Closed -$24K 4085
2018
Q2
$24K Buy
28
+11
+65% +$9.14K ﹤0.01% 2367
2018
Q1
$16K Hold
17
﹤0.01% 2540
2017
Q4
$16K Sell
17
-11
-39% -$10.2K ﹤0.01% 2576
2017
Q3
$31K Buy
28
+14
+100% +$15.9K ﹤0.01% 2325
2017
Q2
$16K Buy
14
+10
+250% +$12.2K ﹤0.01% 2727
2017
Q1
$4K Sell
4
-4
-50% -$3.86K ﹤0.01% 3458
2016
Q4
$8K Buy
8
+4
+100% +$1.81K ﹤0.01% 3068
2016
Q3
$1K Hold
4
﹤0.01% 3806
2016
Q2
$1K Buy
+4
New +$1.96K ﹤0.01% 3721
2016
Q1
Sell
-4
Closed -$2K 3669
2015
Q4
$2K Buy
+4
New +$2.8K ﹤0.01% 3396

Other funds holding HSTO

IFP Advisors's HSTO Position: Q1 2019 in Review

IFP Advisors sold out of Histogen Inc. Common Stock (HSTO) in Q1 2019, closing a stake of 41 shares — an estimated $11K sold.

IFP Advisors first reported a position in HSTO in Q4 2015 and held it in 11 quarters. The position peaked at $31K in Q3 2017. 42 funds tracked by Wall St. Rank hold HSTO as of Q1 2019.

  • IFP Advisors reported no remaining Histogen Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
  • IFP Advisors sold 41 Histogen Inc. Common Stock shares in Q1 2019, an estimated $11K.
  • IFP Advisors first reported a position in Histogen Inc. Common Stock in Q4 2015 and held it in 11 quarters.
  • IFP Advisors's Histogen Inc. Common Stock position peaked at $31K in Q3 2017.
  • 42 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q1 2019.

Based on IFP Advisors's 13F filing for Q1 2019, filed 15 May 2019.